Table S1. Clinical-pathological characteristics of the 37 colon cancer patients included in the study. (XLSX 12Â kb
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Cohorts, ethnicity, and tumor stage of samples used for WES, SNP array, and qPCR. Table S2. Regions ...
Table S1. Characteristics of antibodies used in immunohistochemical staining. (PDF 499Â kb
Table S3. List of mutated RTKs in each patient included in the study. (XLSX 11Â kb
Table S5. List of mutations identified in CC20 after the next generation sequencing analysis pipelin...
Table S1. Mutation rate of 40 genes included in the study. Table S2. Mutation rate of critical pathw...
Table S3. Detailed information for all detected gene mutations. List of all gene mutations detected ...
BACKGROUND: Improvement in genetic characterization of Colon Cancer (CC) patients is required to pr...
Figure S1. Result of sanger sequencing. (A) Eleven mutations which were sanger sequenced. (B) - (H) ...
List of genes from the five different RT² Profiler™ PCR Array Human Systems used in this study, clas...
Inclusion and exclusion criteria for somatic mutation analysis. MSI-H, POLE mutation samples, rectos...
Tables S1-S3. PicNiC statistics (bic and aic) for RCC, LCC and rectal cancers. (XLSX 43 kb
Table S1. Sample details. Table S2. BMP5 primer sequences. Table S3. qPCR Primers used in this study...
Table S1. Private mutations. Abbreviations: SIFT (sort intolerant from tolerant), PP (mutation priva...
Table S1. Top ten most significant common SNPs identified based on the univariable analyses and the ...
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Cohorts, ethnicity, and tumor stage of samples used for WES, SNP array, and qPCR. Table S2. Regions ...
Table S1. Characteristics of antibodies used in immunohistochemical staining. (PDF 499Â kb
Table S3. List of mutated RTKs in each patient included in the study. (XLSX 11Â kb
Table S5. List of mutations identified in CC20 after the next generation sequencing analysis pipelin...
Table S1. Mutation rate of 40 genes included in the study. Table S2. Mutation rate of critical pathw...
Table S3. Detailed information for all detected gene mutations. List of all gene mutations detected ...
BACKGROUND: Improvement in genetic characterization of Colon Cancer (CC) patients is required to pr...
Figure S1. Result of sanger sequencing. (A) Eleven mutations which were sanger sequenced. (B) - (H) ...
List of genes from the five different RT² Profiler™ PCR Array Human Systems used in this study, clas...
Inclusion and exclusion criteria for somatic mutation analysis. MSI-H, POLE mutation samples, rectos...
Tables S1-S3. PicNiC statistics (bic and aic) for RCC, LCC and rectal cancers. (XLSX 43 kb
Table S1. Sample details. Table S2. BMP5 primer sequences. Table S3. qPCR Primers used in this study...
Table S1. Private mutations. Abbreviations: SIFT (sort intolerant from tolerant), PP (mutation priva...
Table S1. Top ten most significant common SNPs identified based on the univariable analyses and the ...
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Cohorts, ethnicity, and tumor stage of samples used for WES, SNP array, and qPCR. Table S2. Regions ...
Table S1. Characteristics of antibodies used in immunohistochemical staining. (PDF 499Â kb